Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCL1 | Q07820 | 1/20 | 0.33 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.33 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.31 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.31 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.30 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.30 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.30 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA1 | P00915 | 2/20 | 0.30 |
| ▸ | CA2 | P00918 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20198955 | 1.00 | MCL1 (0.33) | MCL1ACMSDENPP3ENPP1CHRNB4 | |
| SCHEMBL20174762 | 0.92 | PDK2 (0.32) | CA12CA1CA2CA9 | |
| SCHEMBL20174766 | 0.92 | PDK2 (0.32) | CA12CA1CA2CA9 | |
| SCHEMBL20174752 | 0.92 | PDK2 (0.32) | CA12CA1CA2CA9 | |
| SCHEMBL20174751 | 0.92 | PDK2 (0.32) | CA12CA1CA2CA9 | |
| SCHEMBL20174744 | 0.92 | PDK2 (0.33) | — | |
| SCHEMBL20179314 | 0.92 | PDK2 (0.33) | — | |
| SCHEMBL20174750 | 0.92 | PDK2 (0.33) | — | |
| SCHEMBL20198890 | 0.92 | PDK2 (0.33) | — | |
| SCHEMBL20174980 | 0.91 | MCL1 (0.30) | MCL1ACMSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11075342-B2 | Spiro-type compound and organic light emitting diode comprising same | LG CHEM, LTD. | 2021-07-27 | — | — | US | disclosed |
| US-20180145261-A1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145261-A1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11075342-B2 | Spiro-type compound and organic light emitting diode comprising same | CRY1, NR2E3, ALDH1A2 | MCL1 4066/4885ACMSD 3537/4885ENPP3 2931/4885 |
| US-20180145261-A1 | SPIRO-TYPE COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME | CRY1, NR2E3, ALDH1A2 | MCL1 4066/4885ACMSD 3537/4885ENPP3 2931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.